<DOC>
	<DOCNO>NCT02043483</DOCNO>
	<brief_summary>Untreated Obstructive Sleep Apnea Syndrome ( OSAS ) long-term complication , namely metabolic imbalance ( obesity , dislipidemia , type 2 diabetes mellitus ) . Until , molecular marker physiopathological connection identify . This project aim determine non-invasive biomarkers may allow good comprehension metabolic consequence OSAS , well assess effect Continuous positive airway pressure ( CPAP ) metabolic parameter . This project integrate clinical , metabolic , genetic/proteomic biologic system explore mechanism behind OSAS , well effect treatment CPAP .</brief_summary>
	<brief_title>Identification Biomarkers Obstructive Sleep Apnoea Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Male 2560 year Mild/Moderate/Severe OSAS Female Other sleep disorder Previous CPAP therapy Type 1 diabetes mellitus Familiar Dyslipidemia Severe organ pathology Acute disease</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>CPAP</keyword>
	<keyword>OSAS</keyword>
	<keyword>CEDOC ( Centro de Estudos de Doenças Crónicas )</keyword>
	<keyword>FCM ( Faculdade de Ciências Médicas )</keyword>
	<keyword>UNL ( Universidade Nova de Lisboa</keyword>
	<keyword>NOVA MEDICAL SCHOOL</keyword>
	<keyword>FCT ( Fundação para Ciência e Tecnologia )</keyword>
</DOC>